Solid Biosciences (SLDB) Prepaid Assets (2017 - 2026)
Solid Biosciences (SLDB) reported Prepaid Assets of $15.5 million for Q1 2026, up 138.33% on a YoY basis from $6.5 million in Q1 2025, and down 5.58% sequentially from $16.4 million in Q4 2025.
Solid Biosciences (SLDB) Prepaid Assets (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 10 years of Prepaid Assets data on file, last reported at $15.5 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 138.33% year-over-year to $15.5 million; the trailing twelve-month figure through Mar 2026 stood at $15.5 million (up 138.33% YoY), and the FY2025 full-year result was $16.4 million, up 95.47% from the prior year.
- Prepaid Assets slipped to $15.5 million in Q1 2026, from $16.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $18.5 million in Q1 2022 to a low of $5.1 million in Q1 2023.
- A 5-year average of $8.9 million and a median of $7.3 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 236.06% in 2022 and plunged 72.52% in 2023, its largest moves.
- Tracing SLDB's Prepaid Assets over 5 years: stood at $5.9 million in 2022, then grew by 3.01% to $6.1 million in 2023, then soared by 37.55% to $8.4 million in 2024, then surged by 95.47% to $16.4 million in 2025, then slipped by 5.58% to $15.5 million in 2026.
- Business Quant data shows SLDB's Prepaid Assets at $15.5 million in Q1 2026, $16.4 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.47 Mn |
| Dec 31, 2025 | 16.38 Mn |
| Sep 30, 2025 | 8.71 Mn |
| Jun 30, 2025 | 10.53 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 7.34 Mn |
| Mar 31, 2024 | 8.13 Mn |
| Dec 31, 2023 | 6.09 Mn |
| Sep 30, 2023 | 5.46 Mn |
| Jun 30, 2023 | 7.28 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 5.12 Mn |
| Jun 30, 2022 | 7.32 Mn |
| Mar 31, 2022 | 18.54 Mn |
| Dec 31, 2021 | 14.72 Mn |
| Sep 30, 2021 | 8.37 Mn |
| Jun 30, 2021 | 5.74 Mn |